{"article_title": "Goldman Sachs-Backed Firm Partners To Move MRIs Into The Cloud", "article_keywords": ["firm", "partners", "goldman", "mris", "sachsbacked", "cloud"], "article_url": "http://www.forbes.com/sites/brucejapsen/2015/12/14/imaging-advantage-radnet-partner-to-move-mris-into-the-cloud/", "article_text": "", "article_metadata": {"description": "Once-rival radiology services firms Imaging Advantage and RadNet (RDNT) are partnering to bring lower imaging costs to the healthcare system as fee-for-service medicine that has rewarded unnecessary test-ordering moves to a value-based care model. Imaging Advantage, which is backed by Goldman Sachs (GS), and RadNet say they have signed a deal [...]", "author": "Bruce Japsen", "og": {"site_name": "Forbes", "description": "Once-rival radiology services firms Imaging Advantage and RadNet (RDNT) are partnering to bring lower imaging costs to the healthcare system as fee-for-service medicine that has rewarded unnecessary test-ordering moves to a value-based care model. Imaging Advantage, which is backed by Goldman Sachs (GS), and RadNet say they have signed a deal [...]", "title": "Goldman Sachs-Backed Firm Partners To Move MRIs Into The Cloud", "url": "http://www.forbes.com/sites/brucejapsen/2015/12/14/imaging-advantage-radnet-partner-to-move-mris-into-the-cloud/", "image": "http://blogs-images.forbes.com/brucejapsen/files/2015/12/DMC1-1200x662.jpg", "updated_time": "2015-12-17T00:02:35-05:00", "type": "article"}, "twitter": {"description": "Once-rival radiology services firms Imaging Advantage and RadNet (RDNT) are partnering to bring lower imaging costs to the healthcare system as fee-for-service medicine that has rewarded unnecessary test-ordering moves to a value-based care model. Imaging Advantage, which is backed by Goldman Sachs (GS), and RadNet say they have signed a deal [...]", "creator": "@brucejapsen", "image": "http://blogs-images.forbes.com/brucejapsen/files/2015/12/DMC1-1200x662.jpg", "title": "Goldman Sachs-Backed Firm Partners To Move MRIs Into The Cloud", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Business,Health,Healthcare Innovation,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/business", "section": "Business", "modified": "2015-12-17", "published": "2015-12-14", "id": "blogAndPostId/blog/post/2125-13587"}, "news_keywords": "Business,Health,Healthcare Innovation,Lifestyle,Pharma and Health,Retail,Wall Street,Washington,Pharma &amp; Healthcare,The Economy", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "_id": "\"57477af36914bd0286fd2323\"", "article_summary": ""}